It improves neutrophils function and is quite effective in Anti Phospholipid syndrome
and may result in 50% increase in pregnancy in infertility cases.
KEY WORDS: Anti cardiolipin antibody, Anti phospholipid syndrome
, Recurrent pregnancy loss.
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the anti phospholipid syndrome [Review].
Pathophysiology of the anti phospholipid syndrome [Review].
Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary anti phospholipid syndrome.
International consensus statement on preliminary classification criteria for definite anti phospholipid syndrome.
Clinical manifestations of the anti phospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycopro tein-I than with anti phospholipid antibodies.
Guidelines on the investigation and management of the anti phospholipid syndrome
Increased levels of [beta] glycoprotein-I antigen and [beta]glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary anti phospholipid syndrome.
Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis-prone patients with systemic lupus erythematosus and the anti phospholipid syndrome.
The role of the tissue factor pathway in the hypercoagulable state in patients with the anti phospholipid syndrome.